← Leaderboards
Ulrike Klueh
Iasis Molecular Sciences, Inc
$3,719,377
Attributed
$6,340,309
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,340,309 · 7
By mechanism
R01$4,128,164 · 2
R43$1,758,623 · 4
R21$453,522 · 1
Top collaborators
- Don L Kreutzer8 shared
- Roshanak Sharafieh7 shared
- David J Vachon3 shared
- Beiyan Zhou2 shared
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationTissuesSiteDevicesIn VivoFibrosisMouse ModelIn VitroFutureSubcutaneousCellsBlood GlucoseInflammatoryMacrophageSkinLongevityTechnologyPharmaceutical PreparationsReactionPreventLifeDiabetes MellitusInjectionsInfusion Pumps
Grant awards (14)
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy$650,525
R01 · FY2025 · DK · contact PI
Infusion device optimization by addressing root causes of the inflammatory response$510,643
R01 · FY2025 · DK · contact PI
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy$649,049
R01 · FY2024 · DK · contact PI
Infusion device optimization by addressing root causes of the inflammatory response$536,774
R01 · FY2024 · DK · contact PI
A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy$687,883
R01 · FY2023 · DK · contact PI
Infusion device optimization by addressing root causes of the inflammatory response$557,693
R01 · FY2023 · DK · contact PI
Infusion device optimization by addressing root causes of the inflammatory response$535,597
R01 · FY2022 · DK · contact PI
Using Modified Synthetic MicroRNAs to Control Foreign Body Reactions In Vivo$206,261
R21 · FY2021 · AI
Using Modified Synthetic MicroRNAs to Control Foreign Body Reactions In Vivo$247,261
R21 · FY2020 · AI
Development and Validation of Novel Coatings that Extend Glucose Sensor Accuracy and Lifespan in vivo$298,525
R43 · FY2019 · DK
Use of Stem Cells to Enhance and Extend Continuous Glucose Monitoring in Vivo$270,000
R43 · FY2018 · DK
Development of a Novel Composite Surgical Mesh$345,310
R43 · FY2012 · GM · contact PI
Novel approaches to extending glucose sensor lifespan$403,405
R43 · FY2010 · DK
Novel approaches to extending glucose sensor lifespan$441,383
R43 · FY2009 · DK